145 related articles for article (PubMed ID: 19432901)
21. Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition.
Avizienyte E; Fincham VJ; Brunton VG; Frame MC
Mol Biol Cell; 2004 Jun; 15(6):2794-803. PubMed ID: 15075377
[TBL] [Abstract][Full Text] [Related]
22. RPTPα controls epithelial adherens junctions, linking E-cadherin engagement to c-Src-mediated phosphorylation of cortactin.
Truffi M; Dubreuil V; Liang X; Vacaresse N; Nigon F; Han SP; Yap AS; Gomez GA; Sap J
J Cell Sci; 2014 Jun; 127(Pt 11):2420-32. PubMed ID: 24652832
[TBL] [Abstract][Full Text] [Related]
23. Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries.
Chang F; Flavahan S; Flavahan NA
J Physiol; 2017 Aug; 595(15):5143-5158. PubMed ID: 28561330
[TBL] [Abstract][Full Text] [Related]
24. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.
Alghisi GC; Ponsonnet L; Rüegg C
PLoS One; 2009; 4(2):e4449. PubMed ID: 19212436
[TBL] [Abstract][Full Text] [Related]
25. Rab5-mediated VE-cadherin internalization regulates the barrier function of the lung microvascular endothelium.
Yang J; Yao W; Qian G; Wei Z; Wu G; Wang G
Cell Mol Life Sci; 2015 Dec; 72(24):4849-66. PubMed ID: 26112597
[TBL] [Abstract][Full Text] [Related]
26. Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway.
Shen Y; Hirsch DS; Sasiela CA; Wu WJ
J Biol Chem; 2008 Feb; 283(8):5127-37. PubMed ID: 18057010
[TBL] [Abstract][Full Text] [Related]
27. Protein tyrosine phosphatase activity is necessary for E-cadherin-activated Src signaling.
McLachlan RW; Yap AS
Cytoskeleton (Hoboken); 2011 Jan; 68(1):32-43. PubMed ID: 20925106
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases.
Miotti S; Tomassetti A; Facetti I; Sanna E; Berno V; Canevari S
Am J Pathol; 2005 Nov; 167(5):1411-27. PubMed ID: 16251425
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid modulates the association of PTP1B with N-cadherin/catenin complex in SKOV3 ovarian cancer cells.
Huang RY; Wen CC; Liao CK; Wang SH; Chou LY; Wu JC
Cell Biol Int; 2012 Sep; 36(9):833-41. PubMed ID: 22582758
[TBL] [Abstract][Full Text] [Related]
30. Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.
Liu DS; Hoefnagel SJ; Fisher OM; Krishnadath KK; Montgomery KG; Busuttil RA; Colebatch AJ; Read M; Duong CP; Phillips WA; Clemons NJ
Oncotarget; 2016 Dec; 7(50):83342-83358. PubMed ID: 27863424
[TBL] [Abstract][Full Text] [Related]
31. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling.
Avizienyte E; Wyke AW; Jones RJ; McLean GW; Westhoff MA; Brunton VG; Frame MC
Nat Cell Biol; 2002 Aug; 4(8):632-8. PubMed ID: 12134161
[TBL] [Abstract][Full Text] [Related]
32. Activation of Rac by cadherin through the c-Src-Rap1-phosphatidylinositol 3-kinase-Vav2 pathway.
Fukuyama T; Ogita H; Kawakatsu T; Inagaki M; Takai Y
Oncogene; 2006 Jan; 25(1):8-19. PubMed ID: 16170364
[TBL] [Abstract][Full Text] [Related]
33. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.
Deep G; Gangar SC; Agarwal C; Agarwal R
Cancer Prev Res (Phila); 2011 Aug; 4(8):1222-32. PubMed ID: 21546539
[TBL] [Abstract][Full Text] [Related]
34. Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics.
Canel M; Serrels A; Miller D; Timpson P; Serrels B; Frame MC; Brunton VG
Cancer Res; 2010 Nov; 70(22):9413-22. PubMed ID: 21045155
[TBL] [Abstract][Full Text] [Related]
35. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
[TBL] [Abstract][Full Text] [Related]
36. Decreased expression of E-cadherin and Yamamoto-Kohama's mode of invasion highly correlates with lymph node metastasis in esophageal squamous cell carcinoma.
Kaihara T; Kusaka T; Kawamata H; Oda Y; Fujii S; Morita K; Imura J; Fujimori T
Pathobiology; 2001; 69(3):172-8. PubMed ID: 11872963
[TBL] [Abstract][Full Text] [Related]
37. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
[TBL] [Abstract][Full Text] [Related]
38. Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength.
Byers SW; Sommers CL; Hoxter B; Mercurio AM; Tozeren A
J Cell Sci; 1995 May; 108 ( Pt 5)():2053-64. PubMed ID: 7657723
[TBL] [Abstract][Full Text] [Related]
39. Integrin linked kinase regulates endosomal recycling of N-cadherin in melanoma cells.
Gil D; Zarzycka M; Ciołczyk-Wierzbicka D; Laidler P
Cell Signal; 2020 Aug; 72():109642. PubMed ID: 32305668
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin-integrin crosstalk in cancer invasion and metastasis.
Canel M; Serrels A; Frame MC; Brunton VG
J Cell Sci; 2013 Jan; 126(Pt 2):393-401. PubMed ID: 23525005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
